BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12392737)

  • 1. Synthesis and evaluation of water-soluble paclitaxel prodrugs.
    Feng X; Yuan YJ; Wu JC
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3301-3. PubMed ID: 12392737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness.
    Greenwald RB; Gilbert CW; Pendri A; Conover CD; Xia J; Martinez A
    J Med Chem; 1996 Jan; 39(2):424-31. PubMed ID: 8558510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of water-soluble morpholino-decorated paclitaxel prodrugs with remarkably decreased toxicity.
    Feng S; Chen K; Wang C; Jiang X; Dong H; Gong Z; Liu K
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3598-602. PubMed ID: 27311893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of taxoids 5. Synthesis and evaluation of novel water-soluble prodrugs of a 3'-desphenyl-3'-cyclopropyl analogue of docetaxel.
    Yamaguchi T; Harada N; Ozaki K; Arakawa H; Oda K; Nakanishi N; Tsujihara K; Hashiyama T
    Bioorg Med Chem Lett; 1999 Jun; 9(12):1639-44. PubMed ID: 10397492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation.
    Dosio F; Reddy LH; Ferrero A; Stella B; Cattel L; Couvreur P
    Bioconjug Chem; 2010 Jul; 21(7):1349-61. PubMed ID: 20597546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and preclinical characterization of a paclitaxel prodrug with improved antitumor activity and water solubility.
    Niethammer A; Gaedicke G; Lode HN; Wrasidlo W
    Bioconjug Chem; 2001; 12(3):414-20. PubMed ID: 11353540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 2'-carbamate-linked and 2'-carbonate-linked prodrugs of paclitaxel: selective activation by the tumor-associated protease plasmin.
    de Groot FM; van Berkom LW; Scheeren HW
    J Med Chem; 2000 Aug; 43(16):3093-102. PubMed ID: 10956217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of paclitaxel-2'-glycinate conjugated to poly(ethylene glycol): a water-soluble prodrug.
    Pendri A; Conover CD; Greenwald RB
    Anticancer Drug Des; 1998 Jul; 13(5):387-95. PubMed ID: 9702205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
    Wang Y; Xin D; Liu K; Zhu M; Xiang J
    Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel derivatives for targeted therapy of cancer: toward the development of smart taxanes.
    Safavy A; Raisch KP; Khazaeli MB; Buchsbaum DJ; Bonner JA
    J Med Chem; 1999 Nov; 42(23):4919-24. PubMed ID: 10579854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoprodrug of retinoic acid-modified paclitaxel.
    Zhou Z; Yan J; Sun T; Wang X; Xie Z
    Org Biomol Chem; 2017 Nov; 15(45):9611-9615. PubMed ID: 29106434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
    Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
    Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and anticancer activity of phosphonic acid diphosphate derivative of adenine-containing butenolide and its water-soluble derivatives of paclitaxel with high antitumor activity.
    Moosavi-Movahedi AA; Hakimelahi S; Chamani J; Khodarahmi GA; Hassanzadeh F; Luo FT; Ly TW; Shia KS; Yen CF; Jain ML; Kulatheeswaran R; Xue C; Pasdar M; Hakimelahi GH
    Bioorg Med Chem; 2003 Oct; 11(20):4303-13. PubMed ID: 13129566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumor activities of water-soluble benzoylphenylureas.
    Okada H; Kato M; Koyanagi T; Mizuno K
    Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):430-3. PubMed ID: 10212393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new prodrug of paclitaxel: synthesis of Protaxel.
    Seligson AL; Terry RC; Bressi JC; Douglass JG; Sovak M
    Anticancer Drugs; 2001 Apr; 12(4):305-13. PubMed ID: 11335786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery.
    Miller ML; Roller EE; Zhao RY; Leece BA; Ab O; Baloglu E; Goldmacher VS; Chari RV
    J Med Chem; 2004 Sep; 47(20):4802-5. PubMed ID: 15369381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodrugs of 4'-demethyl-4-deoxypodophyllotoxin: synthesis and evaluation of the antitumor activity.
    Kim Y; You YJ; Nam NH; Ahn BZ
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3435-8. PubMed ID: 12419378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elongated multiple electronic cascade and cyclization spacer systems in activatible anticancer prodrugs for enhanced drug release.
    de Groot FM; Loos WJ; Koekkoek R; van Berkom LW; Busscher GF; Seelen AE; Albrecht C; de Bruijn P; Scheeren HW
    J Org Chem; 2001 Dec; 66(26):8815-30. PubMed ID: 11749612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment.
    Zhou S; Hu X; Xia R; Liu S; Pei Q; Chen G; Xie Z; Jing X
    Angew Chem Int Ed Engl; 2020 Dec; 59(51):23198-23205. PubMed ID: 32852145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.